GUILTY PLEA and PLEA AGREEMENTPlea Agreement • September 1st, 2010 • Allergan Inc • Pharmaceutical preparations
The United States Attorney’s Office for the Northern District of Georgia as counsel for the United States, and Defendant ALLERGAN, INC. (“Defendant” or “ALLERGAN”), hereby enter into this Plea Agreement pursuant to Rule 11(c)(1)(C) of the Federal Rules of Criminal Procedure. Defendant, having received a copy of the above-numbered Criminal Information and having been arraigned, hereby pleads GUILTY to Count One of the Criminal Information thereof.
CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND ALLERGAN, INC.Corporate Integrity Agreement • September 1st, 2010 • Allergan Inc • Pharmaceutical preparations
SETTLEMENT AGREEMENTSettlement Agreement • September 1st, 2010 • Allergan Inc • Pharmaceutical preparations
This Settlement Agreement (“Agreement”) is entered into among the United States of America, acting through the United States Department of Justice and the United States Attorney’s Office for the Northern District of Georgia and on behalf of the Office of Inspector General of the Department of Health and Human Services (“OIG-HHS”), the TRICARE Management Activity (“TMA”), the United States Office of Personnel Management (“OPM”), the United States Department of Veterans Affairs (“VA”), and Office of Workers’ Compensation Programs of the United States Department of Labor (“DOL-OWCP”) (collectively “the United States”); Dr. Amy M. Lang, Charles J. Rushin, Cher Beilfuss, Kathleen O’Connor-Masse, and Albert Edward Hallivis (collectively, “Relators”); Allergan, Inc. and Allergan USA, Inc. (referred to individually and collectively as “Allergan”), through their authorized representatives. Collectively, all of the above will be referred to as “the Parties.”
